| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.626 | 0.004 | 0.626 | Calcium channel L-type activator | |||
| 0.611 | 0.004 | 0.635 | Alpha-N-acetylglucosaminidase inhibitor | 0.635 0.004 DBMET02102 | DBMET02102 | |
| 0.594 | 0.004 | 0.594 | Interleukin 2 agonist | 0.539 0.005 DBMET02102 | ||
| 0.59 | 0.003 | 0.798 | GABA C receptor agonist | 0.798 0.001 DBMET02102 | DBMET02102 | |
| 0.566 | 0.005 | 0.566 | Interleukin agonist | 0.563 0.006 DBMET02102 | ||
| 0.567 | 0.015 | 0.684 | Immunomodulator | 0.684 0.006 DBMET02102 | DBMET02102 | |
| 0.546 | 0.008 | 0.581 | Psychostimulant | 0.581 0.007 DBMET02102 | DBMET02102 | |
| 0.549 | 0.02 | 0.549 | 5 Hydroxytryptamine release inhibitor | 0.482 0.039 DBMET02102 | ||
| 0.526 | 0.004 | 0.526 | Glutamate receptor antagonist | 0.228 0.019 DBMET02102 | ||
| 0.523 | 0.024 | 0.523 | Vasodilator, peripheral | 0.428 0.047 DBMET02102 | ||
| 0.483 | 0.042 | 0.483 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.321 0.186 DBMET02102 | ||
| 0.477 | 0.048 | 0.477 | Antibacterial | 0.393 0.08 DBMET02102 | ||
| 0.433 | 0.017 | 0.433 | Insulysin inhibitor | 0.424 0.018 DBMET02102 | ||
| 0.442 | 0.04 | 0.502 | Antithrombotic | 0.502 0.029 DBMET02102 | DBMET02102 | |
| 0.392 | 0.004 | 0.418 | Hematopoietic | 0.418 0.004 DBMET02102 | DBMET02102 | |
| 0.389 | 0.004 | 0.539 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.539 0.002 DBMET02102 | DBMET02102 | |
| 0.438 | 0.056 | 0.576 | Histamine release inhibitor | 0.576 0.013 DBMET02102 | DBMET02102 | |
| 0.397 | 0.026 | 0.397 | Calcium channel activator | 0.245 0.154 DBMET02102 | ||
| 0.378 | 0.007 | 0.378 | Cell wall synthesis inhibitor | 0.296 0.01 DBMET02102 | ||
| 0.401 | 0.035 | 0.401 | Vasodilator, coronary | 0.296 0.091 DBMET02102 | ||
| 0.365 | 0.004 | 0.455 | Ferrochelatase inhibitor | 0.455 0.003 DBMET02102 | DBMET02102 | |
| 0.4 | 0.049 | 0.525 | Immunostimulant | 0.525 0.026 DBMET02102 | DBMET02102 | |
| 0.376 | 0.025 | 0.411 | DNA synthesis inhibitor | 0.411 0.02 DBMET02102 | DBMET02102 | |
| 0.421 | 0.099 | 0.421 | Caspase 9 stimulant | 0.41 0.105 DBMET02102 | ||
| 0.339 | 0.017 | 0.339 | Diuretic | 0.264 0.028 DBMET02102 | ||
| 0.325 | 0.005 | 0.325 | NMDA receptor antagonist | 0.287 0.007 DBMET02102 | ||
| 0.38 | 0.071 | 0.38 | GABA C receptor rho-3 antagonist | 0.38 0.071 DBMET02102 | ||
| 0.33 | 0.021 | 0.653 | Tyrosine 3 hydroxylase inhibitor | 0.653 0.003 DBMET02102 | DBMET02102 | |
| 0.354 | 0.051 | 0.354 | Spasmolytic | 0.261 0.086 DBMET02102 | ||
| 0.389 | 0.089 | 0.389 | Analgesic | |||
| 0.317 | 0.018 | 0.317 | Lipocortins synthesis antagonist | 0.241 0.037 DBMET02102 | ||
| 0.358 | 0.061 | 0.463 | Cholesterol antagonist | 0.463 0.038 DBMET02102 | DBMET02102 | |
| 0.295 | 0.005 | 0.406 | Triose-phosphate isomerase inhibitor | 0.406 0.003 DBMET02102 | DBMET02102 | |
| 0.294 | 0.003 | 0.461 | NMDA receptor agonist | 0.461 0.002 DBMET02102 | DBMET02102 | |
| 0.311 | 0.026 | 0.348 | Gastrin inhibitor | 0.348 0.011 DBMET02102 | DBMET02102 | |
| 0.284 | 0.01 | 0.374 | Aminopeptidase B inhibitor | 0.374 0.005 DBMET02102 | DBMET02102 | |
| 0.318 | 0.047 | 0.686 | Platelet antagonist | 0.686 0.005 DBMET02102 | DBMET02102 | |
| 0.31 | 0.04 | 0.575 | 5 Hydroxytryptamine uptake stimulant | 0.575 0.003 DBMET02102 | DBMET02102 | |
| 0.269 | 0.005 | 0.319 | Integrin antagonist | 0.319 0.005 DBMET02102 | DBMET02102 | |
| 0.27 | 0.017 | 0.397 | Succinate dehydrogenase inhibitor | 0.397 0.004 DBMET02102 | DBMET02102 | |
| 0.266 | 0.02 | 0.274 | Hemostatic | 0.274 0.019 DBMET02102 | DBMET02102 | |
| 0.253 | 0.013 | 0.253 | UDP-glucose 4-epimerase inhibitor | 0.128 0.038 DBMET02102 | ||
| 0.252 | 0.012 | 0.252 | Neurotrophic factor | |||
| 0.239 | 0.003 | 0.239 | Dihydroorotase inhibitor | |||
| 0.254 | 0.02 | 0.306 | Neurotensin receptor agonist | 0.306 0.013 DBMET02102 | DBMET02102 | |
| 0.251 | 0.017 | 0.255 | Histone deacetylase SIRT1 inhibitor | 0.255 0.016 DBMET02102 | DBMET02102 | |
| 0.287 | 0.055 | 0.676 | Superoxide dismutase inhibitor | 0.676 0.005 DBMET02102 | DBMET02102 | |
| 0.256 | 0.024 | 0.599 | Phospholipase C inhibitor | 0.599 0.004 DBMET02102 | DBMET02102 | |
| 0.276 | 0.047 | 0.276 | Anticonvulsant | 0.269 0.05 DBMET02102 | ||
| 0.268 | 0.039 | 0.355 | DNA methyltransferase I inhibitor | 0.355 0.013 DBMET02102 | DBMET02102 | |
| 0.229 | 0.003 | 0.229 | AMPA 2 receptor antagonist | 0.15 0.004 DBMET02102 | ||
| 0.279 | 0.056 | 0.29 | Vasodilator | 0.29 0.052 DBMET02102 | DBMET02102 | |
| 0.246 | 0.029 | 0.246 | Amylase inhibitor | 0.237 0.032 DBMET02102 | ||
| 0.287 | 0.07 | 0.584 | Aldehyde oxidase inhibitor | 0.584 0.021 DBMET02102 | DBMET02102 | |
| 0.248 | 0.031 | 0.248 | Tumour necrosis factor antagonist | |||
| 0.275 | 0.059 | 0.486 | Angiogenesis stimulant | 0.486 0.013 DBMET02102 | DBMET02102 | |
| 0.259 | 0.046 | 0.367 | Anesthetic general | 0.367 0.021 DBMET02102 | DBMET02102 | |
| 0.218 | 0.005 | 0.218 | Somatostatin 1 agonist | 0.106 0.03 DBMET02102 | ||
| 0.25 | 0.039 | 0.429 | Anticoagulant | 0.429 0.014 DBMET02102 | DBMET02102 | |
| 0.214 | 0.003 | 0.317 | Glutamate (mGluR3) antagonist | 0.317 0.002 DBMET02102 | DBMET02102 | |
| 0.215 | 0.004 | 0.215 | Neuraminidase inhibitor | |||
| 0.211 | 0.005 | 0.281 | NMDA 2C receptor antagonist | 0.281 0.004 DBMET02102 | DBMET02102 | |
| 0.292 | 0.086 | 0.367 | Sodium/bile acid cotransporter inhibitor | 0.367 0.03 DBMET02102 | DBMET02102 | |
| 0.235 | 0.031 | 0.309 | Interferon gamma antagonist | 0.309 0.019 DBMET02102 | DBMET02102 | |
| 0.208 | 0.006 | 0.436 | Alcohol oxidase inhibitor | 0.436 0.004 DBMET02102 | DBMET02102 | |
| 0.249 | 0.049 | 0.367 | DNA methylase inhibitor | 0.367 0.014 DBMET02102 | DBMET02102 | |
| 0.236 | 0.037 | 0.442 | Thrombolytic | 0.442 0.008 DBMET02102 | DBMET02102 | |
| 0.204 | 0.008 | 0.204 | Electrolyte absorption antagonist | 0.157 0.017 DBMET02102 | ||
| 0.197 | 0.005 | 0.197 | Neuraminidase (influenza) inhibitor | 0.06 0.053 DBMET02102 | ||
| 0.201 | 0.008 | 0.201 | GABA C receptor rho-1 antagonist | 0.201 0.008 DBMET02102 | ||
| 0.204 | 0.012 | 0.237 | GABA C receptor antagonist | 0.237 0.008 DBMET02102 | DBMET02102 | |
| 0.203 | 0.01 | 0.203 | Sphingosine 1-phosphate receptor 5 antagonist | 0.18 0.024 DBMET02102 | ||
| 0.199 | 0.012 | 0.526 | Porphobilinogen synthase inhibitor | 0.526 0.003 DBMET02102 | DBMET02102 | |
| 0.188 | 0.003 | 0.621 | Glutamate (mGluR6) antagonist | 0.621 0.001 DBMET02102 | DBMET02102 | |
| 0.249 | 0.064 | 0.249 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.188 | 0.004 | 0.226 | Kainate receptor antagonist | 0.226 0.004 DBMET02102 | DBMET02102 | |
| 0.233 | 0.051 | 0.666 | Peroxidase inhibitor | 0.666 0.003 DBMET02102 | DBMET02102 | |
| 0.238 | 0.057 | 0.238 | RNA-directed DNA polymerase inhibitor | 0.232 0.062 DBMET02102 | ||
| 0.181 | 0.002 | 0.181 | Integrin alpha2beta1 antagonist | 0.031 0.012 DBMET02102 | ||
| 0.296 | 0.117 | 0.475 | Immunosuppressant | 0.475 0.04 DBMET02102 | DBMET02102 | |
| 0.228 | 0.051 | 0.233 | Nitric-oxide synthase stimulant | 0.233 0.046 DBMET02102 | DBMET02102 | |
| 0.192 | 0.015 | 0.291 | Mucolytic | 0.291 0.004 DBMET02102 | DBMET02102 | |
| 0.18 | 0.003 | 0.18 | NMDA receptor glycine site agonist | 0.135 0.005 DBMET02102 | ||
| 0.178 | 0.005 | 0.189 | NMDA receptor subunit 3B antagonist | 0.189 0.005 DBMET02102 | DBMET02102 | |
| 0.176 | 0.003 | 0.216 | Glutamate (mGluR group III) antagonist | 0.216 0.003 DBMET02102 | DBMET02102 | |
| 0.178 | 0.007 | 0.243 | Biliverdin reductase inhibitor | 0.243 0.004 DBMET02102 | DBMET02102 | |
| 0.173 | 0.003 | 0.173 | Integrin alpha2 antagonist | 0.053 0.01 DBMET02102 | ||
| 0.174 | 0.005 | 0.174 | Angiotensin-converting enzyme inhibitor | 0.162 0.005 DBMET02102 | ||
| 0.193 | 0.027 | 0.405 | Cell adhesion inhibitor | 0.405 0.005 DBMET02102 | DBMET02102 | |
| 0.187 | 0.023 | 0.187 | Microtubule formation inhibitor | 0.155 0.035 DBMET02102 | ||
| 0.178 | 0.015 | 0.178 | Sphingosine 1-phosphate receptor 4 antagonist | 0.16 0.026 DBMET02102 | ||
| 0.165 | 0.005 | 0.165 | NMDA receptor subunit 3A antagonist | 0.165 0.005 DBMET02102 | ||
| 0.175 | 0.014 | 0.176 | Heat shock protein 70 antagonist | 0.176 0.014 DBMET02102 | DBMET02102 | |
| 0.171 | 0.014 | 0.213 | NADH dehydrogenase inhibitor | 0.213 0.009 DBMET02102 | DBMET02102 | |
| 0.17 | 0.013 | 0.79 | Glutamate dehydrogenase inhibitor | 0.79 0.001 DBMET02102 | DBMET02102 | |
| 0.175 | 0.019 | 0.438 | Adenylate kinase inhibitor | 0.438 0.002 DBMET02102 | DBMET02102 | |
| 0.169 | 0.014 | 0.179 | Ca2+-transporting ATPase inhibitor | 0.179 0.008 DBMET02102 | DBMET02102 | |
| 0.159 | 0.004 | 0.159 | Kainate receptor 5 antagonist | 0.131 0.004 DBMET02102 | ||
| 0.164 | 0.01 | 0.507 | Argininosuccinate synthase inhibitor | 0.507 0.002 DBMET02102 | DBMET02102 | |
| 0.167 | 0.013 | 0.167 | NMDA 2 receptor antagonist | 0.118 0.024 DBMET02102 | ||
| 0.174 | 0.021 | 0.475 | Catalase inhibitor | 0.475 0.002 DBMET02102 | DBMET02102 | |
| 0.267 | 0.115 | 0.433 | Transcription factor NF kappa B inhibitor | 0.433 0.056 DBMET02102 | DBMET02102 | |
| 0.155 | 0.004 | 0.257 | Glutamate (mGluR4) antagonist | 0.257 0.003 DBMET02102 | DBMET02102 | |
| 0.152 | 0.004 | 0.219 | AMPA 4 receptor antagonist | 0.219 0.003 DBMET02102 | DBMET02102 | |
| 0.149 | 0.003 | 0.173 | Kainate receptor 2 antagonist | 0.173 0.003 DBMET02102 | DBMET02102 | |
| 0.184 | 0.039 | 0.184 | GABA C receptor rho-2 antagonist | 0.148 0.076 DBMET02102 | ||
| 0.19 | 0.045 | 0.19 | Melanin inhibitor | 0.185 0.048 DBMET02102 | ||
| 0.16 | 0.018 | 0.504 | Histidine decarboxylase inhibitor | 0.504 0.003 DBMET02102 | DBMET02102 | |
| 0.17 | 0.028 | 0.318 | Expectorant | 0.318 0.008 DBMET02102 | DBMET02102 | |
| 0.204 | 0.062 | 0.416 | Hepatoprotectant | 0.416 0.012 DBMET02102 | DBMET02102 | |
| 0.228 | 0.087 | 0.228 | Calpain inhibitor | 0.203 0.111 DBMET02102 | ||
| 0.187 | 0.046 | 0.217 | Protein kinase stimulant | 0.217 0.036 DBMET02102 | DBMET02102 | |
| 0.141 | 0.003 | 0.141 | NMDA receptor glycine site antagonist | |||
| 0.145 | 0.014 | 0.926 | Glutamate decarboxylase inhibitor | 0.926 0.001 DBMET02102 | DBMET02102 | |
| 0.145 | 0.013 | 0.262 | Aminopeptidase I inhibitor | 0.262 0.004 DBMET02102 | DBMET02102 | |
| 0.138 | 0.01 | 0.138 | Glycine receptor antagonist | 0.106 0.027 DBMET02102 | ||
| 0.147 | 0.019 | 0.478 | Phosphofructokinase-1 inhibitor | 0.478 0.002 DBMET02102 | DBMET02102 | |
| 0.131 | 0.003 | 0.177 | Kainate receptor 1 antagonist | 0.177 0.003 DBMET02102 | DBMET02102 | |
| 0.131 | 0.003 | 0.259 | Glutamate (mGluR1) agonist | 0.259 0.002 DBMET02102 | DBMET02102 | |
| 0.2 | 0.074 | 0.331 | Insulin sensitizer | 0.331 0.011 DBMET02102 | DBMET02102 | |
| 0.126 | 0.002 | 0.201 | Kainate receptor agonist | 0.201 0.001 DBMET02102 | DBMET02102 | |
| 0.143 | 0.019 | 0.174 | Glutamate receptor agonist | 0.174 0.014 DBMET02102 | DBMET02102 | |
| 0.225 | 0.103 | 0.63 | 5 Hydroxytryptamine release stimulant | 0.63 0.012 DBMET02102 | DBMET02102 | |
| 0.145 | 0.026 | 0.194 | Creatine kinase inhibitor | 0.194 0.011 DBMET02102 | DBMET02102 | |
| 0.133 | 0.013 | 0.63 | Carbamoyl phosphate synthetase inhibitor | 0.63 0.001 DBMET02102 | DBMET02102 | |
| 0.122 | 0.005 | 0.122 | AMPA 1 receptor antagonist | 0.117 0.005 DBMET02102 | ||
| 0.143 | 0.025 | 0.224 | DOPA decarboxylase inhibitor | 0.224 0.004 DBMET02102 | DBMET02102 | |
| 0.171 | 0.054 | 0.207 | Thiol protease inhibitor | 0.207 0.037 DBMET02102 | DBMET02102 | |
| 0.131 | 0.015 | 0.43 | Phenylalanine 4-hydroxylase inhibitor | 0.43 0.003 DBMET02102 | DBMET02102 | |
| 0.112 | 0.002 | 0.135 | Glutamate (mGluR8) antagonist | 0.135 0.002 DBMET02102 | DBMET02102 | |
| 0.114 | 0.005 | 0.129 | Glutamate (mGluR7) antagonist | 0.129 0.004 DBMET02102 | DBMET02102 | |
| 0.152 | 0.043 | 0.182 | Adenylate cyclase inhibitor | 0.182 0.03 DBMET02102 | DBMET02102 | |
| 0.232 | 0.123 | 0.232 | Nootropic | |||
| 0.112 | 0.005 | 0.112 | Factor XIa inhibitor | |||
| 0.142 | 0.036 | 0.142 | Protein kinase C gamma inhibitor | 0.097 0.083 DBMET02102 | ||
| 0.132 | 0.026 | 0.132 | Acetylcholine nicotinic antagonist | |||
| 0.282 | 0.179 | 0.542 | Cyclophilin D inhibitor | 0.542 0.039 DBMET02102 | DBMET02102 | |
| 0.156 | 0.053 | 0.243 | Adenylate cyclase stimulant | 0.243 0.004 DBMET02102 | DBMET02102 | |
| 0.113 | 0.01 | 0.164 | NMDA 2A receptor antagonist | 0.164 0.006 DBMET02102 | DBMET02102 | |
| 0.118 | 0.017 | 0.489 | GABA aminotransferase inhibitor | 0.489 0.003 DBMET02102 | DBMET02102 | |
| 0.105 | 0.004 | 0.134 | AMPA 3 receptor antagonist | 0.134 0.004 DBMET02102 | DBMET02102 | |
| 0.11 | 0.01 | 0.11 | AMPA receptor antagonist | 0.075 0.019 DBMET02102 | ||
| 0.129 | 0.03 | 0.129 | Acetylcholine M3 receptor agonist | |||
| 0.104 | 0.005 | 0.138 | Integrin alpha4 antagonist | 0.138 0.005 DBMET02102 | DBMET02102 | |
| 0.112 | 0.014 | 0.166 | Acyl-CoA dehydrogenase inhibitor | 0.166 0.008 DBMET02102 | DBMET02102 | |
| 0.1 | 0.004 | 0.1 | Factor XI inhibitor | |||
| 0.1 | 0.004 | 0.1 | Kainate receptor 4 antagonist | 0.087 0.004 DBMET02102 | ||
| 0.198 | 0.102 | 0.308 | Peptidyltransferase inhibitor | 0.308 0.022 DBMET02102 | DBMET02102 | |
| 0.098 | 0.004 | 0.214 | Arginase inhibitor | 0.214 0.001 DBMET02102 | DBMET02102 | |
| 0.168 | 0.075 | 0.2 | Antipruritic | 0.2 0.049 DBMET02102 | DBMET02102 | |
| 0.185 | 0.092 | 0.185 | Histone acetyltransferase inhibitor | |||
| 0.098 | 0.005 | 0.098 | Dihydroorotate oxidase inhibitor | |||
| 0.145 | 0.053 | 0.207 | Cyclooxygenase 3 inhibitor | 0.207 0.016 DBMET02102 | DBMET02102 | |
| 0.097 | 0.006 | 0.103 | Mannosidase inhibitor | 0.103 0.005 DBMET02102 | DBMET02102 | |
| 0.097 | 0.006 | 0.097 | VLA-4 antagonist | 0.09 0.007 DBMET02102 | ||
| 0.118 | 0.027 | 0.204 | Cathepsin G inhibitor | 0.204 0.016 DBMET02102 | DBMET02102 | |
| 0.092 | 0.004 | 0.134 | Kainate receptor 3 antagonist | 0.134 0.003 DBMET02102 | DBMET02102 | |
| 0.174 | 0.086 | 0.292 | Platelet adhesion inhibitor | 0.292 0.036 DBMET02102 | DBMET02102 | |
| 0.097 | 0.009 | 0.313 | Aconitate hydratase inhibitor | 0.313 0.002 DBMET02102 | DBMET02102 | |
| 0.109 | 0.021 | 0.109 | Neuronal nicotinic receptor antagonist | |||
| 0.093 | 0.005 | 0.093 | Integrin alpha5beta1 antagonist | 0.061 0.011 DBMET02102 | ||
| 0.095 | 0.007 | 0.095 | Alpha-mannosidase inhibitor | 0.095 0.007 DBMET02102 | ||
| 0.123 | 0.037 | 0.158 | Anabolic | 0.158 0.014 DBMET02102 | DBMET02102 | |
| 0.106 | 0.022 | 0.106 | CXC chemokine receptor antagonist | |||
| 0.159 | 0.078 | 0.209 | Arachidonic acid antagonist | 0.209 0.025 DBMET02102 | DBMET02102 | |
| 0.086 | 0.004 | 0.086 | NMDA 2D receptor antagonist | 0.03 0.015 DBMET02102 | ||
| 0.086 | 0.005 | 0.086 | Neuraminidase (Influenza A) inhibitor | 0.055 0.017 DBMET02102 | ||
| 0.089 | 0.008 | 0.089 | Prolyl endopeptidase inhibitor | 0.046 0.042 DBMET02102 | ||
| 0.194 | 0.114 | 0.194 | Tumour necrosis factor alpha release inhibitor | |||
| 0.134 | 0.058 | 0.192 | Histone deacetylase class III inhibitor | 0.192 0.022 DBMET02102 | DBMET02102 | |
| 0.084 | 0.009 | 0.084 | Somatostatin 1 antagonist | |||
| 0.135 | 0.059 | 0.222 | Cathepsin H inhibitor | 0.222 0.017 DBMET02102 | DBMET02102 | |
| 0.124 | 0.049 | 0.21 | Nav1.4 sodium channel blocker | 0.21 0.017 DBMET02102 | DBMET02102 | |
| 0.102 | 0.027 | 0.126 | Interferon agonist | 0.126 0.015 DBMET02102 | DBMET02102 | |
| 0.079 | 0.005 | 0.079 | DNA gyrase subunit A inhibitor | |||
| 0.092 | 0.018 | 0.486 | Ornithine carbamoyltransferase inhibitor | 0.486 0.003 DBMET02102 | DBMET02102 | |
| 0.077 | 0.003 | 0.077 | Tryptophan 5 hydroxylase inhibitor | 0.065 0.004 DBMET02102 | ||
| 0.131 | 0.058 | 0.322 | Alkylator | 0.322 0.011 DBMET02102 | DBMET02102 | |
| 0.085 | 0.013 | 0.085 | Melanocortin antagonist | |||
| 0.096 | 0.024 | 0.096 | Neutrophil collagenase inhibitor | 0.096 0.024 DBMET02102 | ||
| 0.084 | 0.011 | 0.084 | Melanocortin 4 antagonist | |||
| 0.092 | 0.021 | 0.092 | MAP kinase kinase 7 inhibitor | 0.086 0.033 DBMET02102 | ||
| 0.08 | 0.009 | 0.088 | Adenine nucleotide translocase inhibitor | 0.088 0.006 DBMET02102 | DBMET02102 | |
| 0.125 | 0.054 | 0.305 | Cystathionine beta-synthase inhibitor | 0.305 0.009 DBMET02102 | DBMET02102 | |
| 0.08 | 0.009 | 0.08 | Antiviral (Hepatitis D) | |||
| 0.133 | 0.063 | 0.133 | Cholinergic antagonist | |||
| 0.102 | 0.032 | 0.116 | Granulocyte macrophage colony stimulating factor agonist | 0.116 0.018 DBMET02102 | DBMET02102 | |
| 0.095 | 0.024 | 0.211 | Glycine receptor agonist | 0.211 0.004 DBMET02102 | DBMET02102 | |
| 0.111 | 0.042 | 0.329 | Alcohol dehydrogenase inhibitor | 0.329 0.005 DBMET02102 | DBMET02102 | |
| 0.13 | 0.062 | 0.13 | Acetylcholine antagonist | |||
| 0.076 | 0.008 | 0.076 | Somatostatin 5 antagonist | |||
| 0.112 | 0.045 | 0.22 | Prolactin inhibitor | 0.22 0.006 DBMET02102 | DBMET02102 | |
| 0.11 | 0.043 | 0.221 | Glutamate (mGluR7) agonist | 0.221 0.004 DBMET02102 | DBMET02102 | |
| 0.29 | 0.225 | 0.407 | Antiinflammatory | 0.407 0.135 DBMET02102 | DBMET02102 | |
| 0.086 | 0.021 | 0.086 | Glutamate (mGluR1) antagonist | |||
| 0.147 | 0.082 | 0.147 | Hexokinase inhibitor | |||
| 0.071 | 0.007 | 0.106 | Membrane dipeptidase inhibitor | 0.106 0.003 DBMET02102 | DBMET02102 | |
| 0.121 | 0.058 | 0.178 | Caspase 3 inhibitor | 0.178 0.014 DBMET02102 | DBMET02102 | |
| 0.104 | 0.042 | 0.104 | Polo-like kinase-1 inhibitor | 0.086 0.07 DBMET02102 | ||
| 0.067 | 0.005 | 0.265 | Lysine carboxypeptidase inhibitor | 0.265 0.002 DBMET02102 | DBMET02102 | |
| 0.071 | 0.01 | 0.071 | Somatostatin agonist | |||
| 0.117 | 0.056 | 0.117 | Falcipain 3 inhibitor | 0.111 0.06 DBMET02102 | ||
| 0.073 | 0.013 | 0.073 | HCV NS3/NS4A protease inhibitor | 0.069 0.015 DBMET02102 | ||
| 0.098 | 0.039 | 0.098 | Metalloproteinase-2 inhibitor | 0.098 0.039 DBMET02102 | ||
| 0.062 | 0.004 | 0.152 | Glutamate (mGluR3) agonist | 0.152 0.001 DBMET02102 | DBMET02102 | |
| 0.085 | 0.027 | 0.101 | Phospholipase D inhibitor | 0.101 0.014 DBMET02102 | DBMET02102 | |
| 0.087 | 0.029 | 0.18 | GABA B receptor agonist | 0.18 0.004 DBMET02102 | DBMET02102 | |
| 0.067 | 0.009 | 0.067 | Glutamate (mGluR group II) antagonist | 0.052 0.015 DBMET02102 | ||
| 0.077 | 0.02 | 0.077 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.129 | 0.073 | 0.129 | CC chemokine 6 receptor antagonist | |||
| 0.067 | 0.011 | 0.067 | Oxytocin agonist | 0.061 0.016 DBMET02102 | ||
| 0.099 | 0.044 | 0.149 | Glutamate release inhibitor | 0.149 0.01 DBMET02102 | DBMET02102 | |
| 0.084 | 0.029 | 0.084 | CXC chemokine 4 receptor antagonist | |||
| 0.082 | 0.028 | 0.082 | Protein kinase C beta inhibitor | |||
| 0.064 | 0.011 | 0.064 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.141 | 0.088 | 0.154 | Protein-tyrosine phosphatase inhibitor | 0.154 0.074 DBMET02102 | DBMET02102 | |
| 0.077 | 0.024 | 0.086 | MDM2 inhibitor | 0.086 0.014 DBMET02102 | DBMET02102 | |
| 0.104 | 0.052 | 0.155 | Interleukin 1 beta converting enzyme inhibitor | 0.155 0.015 DBMET02102 | DBMET02102 | |
| 0.054 | 0.002 | 0.054 | Neuraminidase (Influenza B) inhibitor | 0.028 0.005 DBMET02102 | ||
| 0.072 | 0.021 | 0.072 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.065 | 0.015 | 0.065 | 5-Alpha-reductase inhibitor | 0.034 0.029 DBMET02102 | ||
| 0.061 | 0.01 | 0.478 | Fumarate hydratase inhibitor | 0.478 0.002 DBMET02102 | DBMET02102 | |
| 0.071 | 0.021 | 0.071 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.055 | 0.005 | 0.252 | Glutamate (mGluR1a) agonist | 0.252 0.002 DBMET02102 | DBMET02102 | |
| 0.058 | 0.008 | 0.314 | Glutamate (mGluR8) agonist | 0.314 0.001 DBMET02102 | DBMET02102 | |
| 0.097 | 0.047 | 0.252 | Ornithine decarboxylase inhibitor | 0.252 0.004 DBMET02102 | DBMET02102 | |
| 0.055 | 0.005 | 0.055 | Cyclophilin A inhibitor | |||
| 0.112 | 0.062 | 0.352 | Chelator | 0.352 0.008 DBMET02102 | DBMET02102 | |
| 0.078 | 0.029 | 0.102 | Protease 3C (Human rhinovirus) inhibitor | 0.102 0.015 DBMET02102 | DBMET02102 | |
| 0.084 | 0.035 | 0.113 | Opioid delta receptor antagonist | 0.113 0.027 DBMET02102 | DBMET02102 | |
| 0.098 | 0.049 | 0.108 | Opioid antagonist | 0.108 0.042 DBMET02102 | DBMET02102 | |
| 0.136 | 0.088 | 0.137 | Neuropeptide Y1 antagonist | 0.137 0.086 DBMET02102 | DBMET02102 | |
| 0.056 | 0.009 | 0.056 | Baculoviral IAP repeat-containing protein inhibitor | |||
| 0.136 | 0.089 | 0.136 | Acetylcholine M1 receptor antagonist | 0.129 0.096 DBMET02102 | ||
| 0.075 | 0.028 | 0.075 | Bombesin 1 receptor agonist | 0.055 0.047 DBMET02102 | ||
| 0.136 | 0.09 | 0.255 | Insulin secretagoues | 0.255 0.018 DBMET02102 | DBMET02102 | |
| 0.126 | 0.081 | 0.193 | Sphingosine 1-phosphate receptor 2 antagonist | 0.193 0.009 DBMET02102 | DBMET02102 | |
| 0.086 | 0.041 | 0.12 | Keratolytic | 0.12 0.022 DBMET02102 | DBMET02102 | |
| 0.07 | 0.025 | 0.075 | Sphingosine kinase inhibitor | 0.075 0.02 DBMET02102 | DBMET02102 | |
| 0.057 | 0.014 | 0.057 | Guanylate cyclase inhibitor | 0.045 0.027 DBMET02102 | ||
| 0.071 | 0.029 | 0.071 | Androgen agonist | |||
| 0.06 | 0.018 | 0.128 | Glucose-6-phosphate isomerase inhibitor | 0.128 0.003 DBMET02102 | DBMET02102 | |
| 0.055 | 0.014 | 0.055 | Somatostatin 2 antagonist | |||
| 0.068 | 0.027 | 0.068 | Prolactin release inhibitor | |||
| 0.098 | 0.057 | 0.123 | Potassium channel (Ca-activated) activator | 0.123 0.039 DBMET02102 | DBMET02102 | |
| 0.113 | 0.072 | 0.128 | Proteasome inhibitor | 0.128 0.06 DBMET02102 | DBMET02102 | |
| 0.043 | 0.003 | 0.043 | Tryptophan hydroxylase 1 inhibitor | 0.028 0.004 DBMET02102 | ||
| 0.109 | 0.069 | 0.109 | Acetylcholine release stimulant | |||
| 0.154 | 0.115 | 0.472 | Interleukin antagonist | 0.472 0.022 DBMET02102 | DBMET02102 | |
| 0.072 | 0.032 | 0.076 | Trypsin inhibitor | 0.076 0.029 DBMET02102 | DBMET02102 | |
| 0.251 | 0.213 | 0.291 | Apoptosis agonist | 0.291 0.179 DBMET02102 | DBMET02102 | |
| 0.068 | 0.03 | 0.068 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.051 DBMET02102 | ||
| 0.047 | 0.009 | 0.054 | Integrin alpha1beta1 antagonist | 0.054 0.005 DBMET02102 | DBMET02102 | |
| 0.068 | 0.03 | 0.068 | Histone deacetylase SIRT3 inhibitor | |||
| 0.064 | 0.027 | 0.064 | Ryanodine receptor antagonist | 0.056 0.051 DBMET02102 | ||
| 0.052 | 0.015 | 0.052 | Angiotensin AT1 receptor antagonist | 0.042 0.029 DBMET02102 | ||
| 0.102 | 0.066 | 0.102 | Beta glucuronidase inhibitor | |||
| 0.113 | 0.078 | 0.305 | Aldehyde dehydrogenase inhibitor | 0.305 0.011 DBMET02102 | DBMET02102 | |
| 0.044 | 0.008 | 0.044 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.054 | 0.019 | 0.118 | AICAR transformylase inhibitor | 0.118 0.004 DBMET02102 | DBMET02102 | |
| 0.04 | 0.005 | 0.04 | Nicotinic acid receptor 2 antagonist | |||
| 0.05 | 0.015 | 0.072 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.072 0.004 DBMET02102 | DBMET02102 | |
| 0.076 | 0.042 | 0.095 | Opioid mu receptor antagonist | 0.095 0.033 DBMET02102 | DBMET02102 | |
| 0.04 | 0.007 | 0.04 | Antidiuretic hormone agonist | |||
| 0.074 | 0.041 | 0.074 | Matrix metalloproteinase inhibitor | 0.067 0.046 DBMET02102 | ||
| 0.078 | 0.046 | 0.078 | Metalloproteinase-9 inhibitor | 0.07 0.056 DBMET02102 | ||
| 0.184 | 0.152 | 0.243 | Neuropeptide Y2 antagonist | 0.243 0.063 DBMET02102 | DBMET02102 | |
| 0.053 | 0.022 | 0.053 | Neurokinin 2 antagonist | |||
| 0.159 | 0.128 | 0.253 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.253 0.041 DBMET02102 | DBMET02102 | |
| 0.097 | 0.066 | 0.097 | Protein kinase (CK2) inhibitor | |||
| 0.084 | 0.052 | 0.084 | CC chemokine 5 receptor agonist | |||
| 0.048 | 0.017 | 0.078 | Calcitonin receptor agonist | 0.078 0.012 DBMET02102 | DBMET02102 | |
| 0.057 | 0.026 | 0.057 | Metalloproteinase-3 inhibitor | 0.051 0.032 DBMET02102 | ||
| 0.051 | 0.021 | 0.051 | Growth hormone release inhibitor | 0.042 0.029 DBMET02102 | ||
| 0.059 | 0.028 | 0.225 | GP IIb/IIIa receptor antagonist | 0.225 0.005 DBMET02102 | DBMET02102 | |
| 0.042 | 0.011 | 0.042 | Angiotensin AT2 receptor antagonist | |||
| 0.066 | 0.035 | 0.066 | Collagenase 3 inhibitor | |||
| 0.044 | 0.013 | 0.062 | AMPA receptor agonist | 0.062 0.005 DBMET02102 | DBMET02102 | |
| 0.061 | 0.031 | 0.061 | Matrix metalloproteinase (membrane-type) inhibitor | 0.061 0.032 DBMET02102 | ||
| 0.07 | 0.041 | 0.116 | Glucagon-like peptide 1 agonist | 0.116 0.015 DBMET02102 | DBMET02102 | |
| 0.092 | 0.063 | 0.177 | HIV-1 integrase (Overall Integration) inhibitor | 0.177 0.017 DBMET02102 | DBMET02102 | |
| 0.064 | 0.035 | 0.064 | Cathepsin E inhibitor | 0.063 0.037 DBMET02102 | ||
| 0.041 | 0.013 | 0.041 | Angiotensin II receptor antagonist | 0.034 0.024 DBMET02102 | ||
| 0.044 | 0.017 | 0.044 | Tryptase inhibitor | |||
| 0.051 | 0.024 | 0.051 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.039 | 0.012 | 0.039 | Glutamate (mGluR2) antagonist | |||
| 0.04 | 0.013 | 0.04 | Protein kinase (CK2) beta inhibitor | |||
| 0.05 | 0.023 | 0.05 | Leukocyte elastase inhibitor | 0.044 0.029 DBMET02102 | ||
| 0.06 | 0.034 | 0.08 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.08 0.02 DBMET02102 | DBMET02102 | |
| 0.035 | 0.009 | 0.035 | Vasopressin 1A agonist | |||
| 0.03 | 0.004 | 0.03 | Baculoviral IAP repeat-containing protein 3 inhibitor | |||
| 0.035 | 0.01 | 0.035 | Somatostatin 4 antagonist | |||
| 0.047 | 0.022 | 0.047 | Nerve growth factor antagonist | 0.039 0.038 DBMET02102 | ||
| 0.116 | 0.091 | 0.116 | Interleukin 4 antagonist | |||
| 0.054 | 0.029 | 0.113 | CD45 antagonist | 0.113 0.008 DBMET02102 | DBMET02102 | |
| 0.034 | 0.009 | 0.041 | Thyroid hormone agonist | 0.041 0.006 DBMET02102 | DBMET02102 | |
| 0.054 | 0.03 | 0.054 | Plasmin inhibitor | |||
| 0.032 | 0.009 | 0.032 | 5-Alpha-reductase 2 inhibitor | |||
| 0.034 | 0.011 | 0.034 | LFA antagonist | 0.028 0.019 DBMET02102 | ||
| 0.058 | 0.035 | 0.058 | Pregnane X receptor antagonist | 0.057 0.038 DBMET02102 | ||
| 0.043 | 0.02 | 0.085 | Cholecystokinin B agonist | 0.085 0.007 DBMET02102 | DBMET02102 | |
| 0.045 | 0.022 | 0.045 | Sphingosine kinase 1 inhibitor | 0.045 0.022 DBMET02102 | ||
| 0.029 | 0.007 | 0.029 | Vasopressin 1 agonist | |||
| 0.055 | 0.033 | 0.055 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.091 | 0.069 | 0.099 | Interleukin 12 antagonist | 0.099 0.055 DBMET02102 | DBMET02102 | |
| 0.095 | 0.074 | 0.285 | Folate antagonist | 0.285 0.004 DBMET02102 | DBMET02102 | |
| 0.032 | 0.011 | 0.032 | 1,3-Beta-glucan synthase inhibitor | |||
| 0.047 | 0.026 | 0.26 | Glutamate (mGluR group III) agonist | 0.26 0.003 DBMET02102 | DBMET02102 | |
| 0.077 | 0.057 | 0.344 | Cell adhesion molecule inhibitor | 0.344 0.005 DBMET02102 | DBMET02102 | |
| 0.049 | 0.028 | 0.091 | Neurotensin receptor antagonist | 0.091 0.016 DBMET02102 | DBMET02102 | |
| 0.038 | 0.018 | 0.038 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.052 | 0.032 | 0.092 | Lysophosphatidic acid 3 receptor antagonist | 0.092 0.006 DBMET02102 | DBMET02102 | |
| 0.036 | 0.016 | 0.045 | Prostaglandin D2 agonist | 0.045 0.01 DBMET02102 | DBMET02102 | |
| 0.038 | 0.018 | 0.038 | Carnitine palmitoyltransferase inhibitor | |||
| 0.038 | 0.02 | 0.038 | RNA-directed RNA polymerase inhibitor | |||
| 0.082 | 0.063 | 0.107 | Factor XII inhibitor | 0.107 0.031 DBMET02102 | DBMET02102 | |
| 0.031 | 0.013 | 0.031 | Motilin receptor antagonist | |||
| 0.061 | 0.043 | 0.088 | Purinergic P2X1 antagonist | 0.088 0.021 DBMET02102 | DBMET02102 | |
| 0.033 | 0.015 | 0.033 | Uridine phosphorylase inhibitor | 0.032 0.016 DBMET02102 | ||
| 0.166 | 0.149 | 0.172 | 5 Hydroxytryptamine 3E antagonist | 0.172 0.13 DBMET02102 | DBMET02102 | |
| 0.049 | 0.032 | 0.08 | Adenosine deaminase inhibitor | 0.08 0.009 DBMET02102 | DBMET02102 | |
| 0.023 | 0.007 | 0.023 | Vasopressin 2 agonist | |||
| 0.026 | 0.01 | 0.027 | Integrin beta5 antagonist | 0.027 0.01 DBMET02102 | DBMET02102 | |
| 0.041 | 0.025 | 0.489 | Leukotriene A4 hydrolase inhibitor | 0.489 0.003 DBMET02102 | DBMET02102 | |
| 0.024 | 0.008 | 0.028 | Integrin alpha4beta1 antagonist | 0.028 0.007 DBMET02102 | DBMET02102 | |
| 0.024 | 0.008 | 0.024 | Prostaglandin EP4 agonist | |||
| 0.076 | 0.06 | 0.108 | Chymotrypsin inhibitor | 0.108 0.031 DBMET02102 | DBMET02102 | |
| 0.04 | 0.025 | 0.04 | Melanocortin 1 antagonist | |||
| 0.071 | 0.056 | 0.084 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.084 0.03 DBMET02102 | DBMET02102 | |
| 0.028 | 0.013 | 0.028 | Prostaglandin EP2 agonist | |||
| 0.025 | 0.011 | 0.025 | Somatostatin 3 antagonist | |||
| 0.095 | 0.081 | 0.179 | Factor V inhibitor | 0.179 0.009 DBMET02102 | DBMET02102 | |
| 0.093 | 0.078 | 0.095 | Carbonic anhydrase XV inhibitor | 0.095 0.074 DBMET02102 | DBMET02102 | |
| 0.094 | 0.08 | 0.169 | Monophenol monooxygenase inhibitor | 0.169 0.041 DBMET02102 | DBMET02102 | |
| 0.072 | 0.059 | 0.115 | Analgesic, opioid | 0.115 0.025 DBMET02102 | DBMET02102 | |
| 0.069 | 0.056 | 0.096 | Thrombin inhibitor | 0.096 0.028 DBMET02102 | DBMET02102 | |
| 0.037 | 0.024 | 0.037 | Nicotinic acid receptor agonist | |||
| 0.051 | 0.039 | 0.061 | Dipeptidyl peptidase inhibitor | 0.061 0.025 DBMET02102 | DBMET02102 | |
| 0.039 | 0.027 | 0.058 | GABA uptake inhibitor | 0.058 0.011 DBMET02102 | DBMET02102 | |
| 0.048 | 0.036 | 0.081 | Bombesin 2 receptor antagonist | 0.081 0.017 DBMET02102 | DBMET02102 | |
| 0.032 | 0.02 | 0.032 | Prostaglandin agonist | 0.028 0.025 DBMET02102 | ||
| 0.059 | 0.048 | 0.059 | Heme oxygenase stimulant | |||
| 0.054 | 0.043 | 0.054 | Kallikrein 1 inhibitor | |||
| 0.022 | 0.01 | 0.022 | 5-Alpha-reductase 1 inhibitor | |||
| 0.029 | 0.018 | 0.037 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.037 0.013 DBMET02102 | DBMET02102 | |
| 0.021 | 0.01 | 0.07 | Aminopeptidase A inhibitor | 0.07 0.003 DBMET02102 | DBMET02102 | |
| 0.08 | 0.069 | 0.08 | mTOR complex 2 inhibitor | |||
| 0.039 | 0.029 | 0.055 | Dopamine D5 agonist | 0.055 0.014 DBMET02102 | DBMET02102 | |
| 0.089 | 0.079 | 0.089 | Phosphodiesterase 6D inhibitor | |||
| 0.122 | 0.112 | 0.122 | NOS3 expression enhancer | |||
| 0.114 | 0.104 | 0.202 | Vanilloid 1 agonist | 0.202 0.011 DBMET02102 | DBMET02102 | |
| 0.08 | 0.07 | 0.08 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.035 | 0.025 | 0.037 | Growth factor receptor-bound protein 2 antagonist | 0.037 0.019 DBMET02102 | DBMET02102 | |
| 0.029 | 0.02 | 0.029 | Melanocortin 3 antagonist | |||
| 0.015 | 0.006 | 0.351 | Glutamate (mGluR6) agonist | 0.351 0.001 DBMET02102 | DBMET02102 | |
| 0.137 | 0.127 | 0.137 | ATPase inhibitor | |||
| 0.07 | 0.06 | 0.098 | Na+ K+ transporting ATPase inhibitor | 0.098 0.033 DBMET02102 | DBMET02102 | |
| 0.019 | 0.01 | 0.019 | Angiotensin-converting enzyme 2 inhibitor | |||
| 0.039 | 0.03 | 0.197 | Toll-Like receptor 2 agonist | 0.197 0.007 DBMET02102 | DBMET02102 | |
| 0.031 | 0.022 | 0.031 | Histone deacetylase class IV inhibitor | |||
| 0.031 | 0.022 | 0.031 | Histone deacetylase 11 inhibitor | |||
| 0.017 | 0.008 | 0.017 | Angiotensin AT1B receptor antagonist | |||
| 0.079 | 0.071 | 0.086 | D-Ala-D-Ala ligase inhibitor | 0.086 0.053 DBMET02102 | DBMET02102 | |
| 0.018 | 0.01 | 0.052 | Carbonic anhydrase X inhibitor | 0.052 0.003 DBMET02102 | DBMET02102 | |
| 0.018 | 0.01 | 0.052 | Carbonic anhydrase VIII inhibitor | 0.052 0.003 DBMET02102 | DBMET02102 | |
| 0.019 | 0.011 | 0.024 | Methylmalonyl-CoA mutase inhibitor | 0.024 0.005 DBMET02102 | DBMET02102 | |
| 0.025 | 0.017 | 0.04 | Lysophosphatidic acid receptor 1 agonist | 0.04 0.005 DBMET02102 | DBMET02102 | |
| 0.037 | 0.029 | 0.037 | Oxytocin antagonist | |||
| 0.022 | 0.014 | 0.094 | Neutral endopeptidase inhibitor | 0.094 0.005 DBMET02102 | DBMET02102 | |
| 0.03 | 0.022 | 0.034 | Lysophosphatidic acid 2 receptor antagonist | 0.034 0.017 DBMET02102 | DBMET02102 | |
| 0.107 | 0.099 | 0.3 | Bone formation stimulant | 0.3 0.017 DBMET02102 | DBMET02102 | |
| 0.042 | 0.035 | 0.051 | Dipeptidyl peptidase IV inhibitor | 0.051 0.019 DBMET02102 | DBMET02102 | |
| 0.02 | 0.013 | 0.02 | Melatonin 3 antagonist | |||
| 0.054 | 0.048 | 0.174 | Carbonic anhydrase stimulant | 0.174 0.009 DBMET02102 | DBMET02102 | |
| 0.043 | 0.037 | 0.237 | Antimetabolite | 0.237 0.008 DBMET02102 | DBMET02102 | |
| 0.03 | 0.024 | 0.03 | HCV NS5B polymerase inhibitor | |||
| 0.023 | 0.017 | 0.023 | Growth hormone releasing factor antagonist | |||
| 0.025 | 0.02 | 0.025 | Thymidine phosphorylase inhibitor | |||
| 0.015 | 0.009 | 0.018 | Integrin alphaVbeta6 antagonist | 0.018 0.007 DBMET02102 | DBMET02102 | |
| 0.022 | 0.017 | 0.022 | Prostaglandin E2 agonist | |||
| 0.171 | 0.165 | 0.171 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.012 | 0.006 | 0.013 | Thromboxane agonist | 0.013 0.005 DBMET02102 | DBMET02102 | |
| 0.013 | 0.008 | 0.013 | Integrin beta2 antagonist | |||
| 0.021 | 0.016 | 0.051 | Integrin alphaVbeta3 antagonist | 0.051 0.005 DBMET02102 | DBMET02102 | |
| 0.018 | 0.014 | 0.018 | Somatostatin 3 agonist | |||
| 0.127 | 0.123 | 0.127 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.098 | 0.093 | 0.227 | Photosensitizer | 0.227 0.008 DBMET02102 | DBMET02102 | |
| 0.053 | 0.048 | 0.073 | Prostaglandin EP2 antagonist | 0.073 0.031 DBMET02102 | DBMET02102 | |
| 0.012 | 0.008 | 0.012 | Immunosuppressant Cyclosporine-like | |||
| 0.07 | 0.066 | 0.098 | Vanilloid 4 agonist | 0.098 0.018 DBMET02102 | DBMET02102 | |
| 0.017 | 0.013 | 0.02 | Nicotinic acid receptor 1 antagonist | 0.02 0.009 DBMET02102 | DBMET02102 | |
| 0.031 | 0.027 | 0.061 | Carboxypeptidase B inhibitor | 0.061 0.004 DBMET02102 | DBMET02102 | |
| 0.018 | 0.015 | 0.056 | Integrin beta3 antagonist | 0.056 0.006 DBMET02102 | DBMET02102 | |
| 0.021 | 0.018 | 0.021 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.024 | 0.021 | 0.024 | Prostaglandin EP4 antagonist | |||
| 0.043 | 0.041 | 0.043 | Beta adrenoreceptor agonist | |||
| 0.032 | 0.03 | 0.032 | Nicotinic acid receptor 2 agonist | |||
| 0.025 | 0.024 | 0.029 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.029 0.015 DBMET02102 | DBMET02102 | |
| 0.025 | 0.024 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.051 | 0.05 | 0.089 | Sphingosine 1-phosphate receptor 1 antagonist | 0.089 0.012 DBMET02102 | DBMET02102 | |
| 0.086 | 0.085 | 0.114 | Bile acid receptor antagonist | 0.114 0.026 DBMET02102 | DBMET02102 | |
| 0.095 | 0.094 | 0.129 | Cholesterol synthesis inhibitor | 0.129 0.058 DBMET02102 | DBMET02102 | |
| 0.074 | 0.073 | 0.074 | Androgen antagonist | |||
| 0.03 | 0.03 | 0.034 | Free fatty acid receptor 1 antagonist | 0.034 0.024 DBMET02102 | DBMET02102 | |
| 0.037 | 0.037 | 0.039 | Thymidine kinase inhibitor | 0.039 0.032 DBMET02102 | DBMET02102 | |
| 0.018 | 0.018 | 0.027 | Caspase 8 inhibitor | 0.027 0.006 DBMET02102 | DBMET02102 | |
| 0.077 | 0.078 | 0.097 | Estrogen-related receptor beta agonist | 0.097 0.029 DBMET02102 | DBMET02102 | |
| 0.028 | 0.028 | 0.038 | Trypsin I inhibitor | 0.038 0.019 DBMET02102 | DBMET02102 | |
| 0.051 | 0.054 | 0.077 | Sphingosine 1-phosphate receptor 3 antagonist | 0.077 0.019 DBMET02102 | DBMET02102 | |
| 0.049 | 0.051 | 0.08 | Thromboxane synthase inhibitor | 0.08 0.012 DBMET02102 | DBMET02102 | |
| 0.022 | 0.025 | 0.046 | Vanilloid 2 agonist | 0.046 0.003 DBMET02102 | DBMET02102 | |
| 0.016 | 0.019 | 0.02 | Neurokinin 1 agonist | 0.02 0.015 DBMET02102 | DBMET02102 | |
| 0.005 | 0.008 | 0.008 | Integrin alpha5beta6 antagonist | 0.008 0.004 DBMET02102 | DBMET02102 | |
| 0.117 | 0.121 | 0.275 | Phospholipase A2 inhibitor | 0.275 0.018 DBMET02102 | DBMET02102 | |
| 0.038 | 0.042 | 0.073 | Sphingosine 1-phosphate receptor agonist | 0.073 0.01 DBMET02102 | DBMET02102 | |
| 0.006 | 0.011 | 0.015 | Integrin alphaVbeta5 antagonist | 0.015 0.005 DBMET02102 | DBMET02102 | |
| 0.014 | 0.02 | 0.027 | Telomerase stimulant | 0.027 0.004 DBMET02102 | DBMET02102 | |
| 0.018 | 0.024 | 0.022 | Retinoid X beta receptor antagonist | 0.022 0.011 DBMET02102 | DBMET02102 | |
| 0.01 | 0.016 | 0.017 | Carbonic anhydrase XI inhibitor | 0.017 0.005 DBMET02102 | DBMET02102 | |
| 0.018 | 0.024 | 0.03 | Aminopeptidase P inhibitor | 0.03 0.01 DBMET02102 | DBMET02102 | |
| 0.01 | 0.016 | 0.022 | Lysophosphatidic acid receptor 3 agonist | 0.022 0.005 DBMET02102 | DBMET02102 | |
| 0.046 | 0.052 | 0.066 | Plasminogen activator inhibitor | 0.066 0.035 DBMET02102 | DBMET02102 | |
| 0.024 | 0.032 | 0.032 | Purinergic P2Y15 antagonist | 0.032 0.013 DBMET02102 | DBMET02102 | |
| 0.024 | 0.032 | 0.05 | Peptide deformylase inhibitor | 0.05 0.01 DBMET02102 | DBMET02102 | |
| 0.034 | 0.043 | 0.073 | Sphingosine 1-phosphate receptor 1 agonist | 0.073 0.008 DBMET02102 | DBMET02102 | |
| 0.038 | 0.047 | 0.042 | Glutamate (mGluR group I) agonist | 0.042 0.04 DBMET02102 | DBMET02102 | |
| 0.082 | 0.092 | 0.199 | Nitric-oxide synthase inhibitor | 0.199 0.009 DBMET02102 | DBMET02102 | |
| 0.037 | 0.046 | 0.141 | Thymidylate synthase inhibitor | 0.141 0.003 DBMET02102 | DBMET02102 | |
| 0.032 | 0.041 | 0.058 | Dihydropteroate synthase inhibitor | 0.058 0.013 DBMET02102 | DBMET02102 | |
| 0.187 | 0.198 | 0.606 | Apoptosis antagonist | 0.606 0.009 DBMET02102 | DBMET02102 | |
| 0.034 | 0.045 | 0.06 | Phosphorylase inhibitor | 0.06 0.025 DBMET02102 | DBMET02102 | |
| 0.026 | 0.037 | 0.055 | Dipeptidyl peptidase II inhibitor | 0.055 0.008 DBMET02102 | DBMET02102 | |
| 0.085 | 0.096 | 0.104 | Protein-tyrosine phosphatase 1B inhibitor | 0.104 0.074 DBMET02102 | DBMET02102 | |
| 0.036 | 0.048 | 0.063 | Opioid mu receptor agonist | 0.063 0.022 DBMET02102 | DBMET02102 | |
| 0.015 | 0.028 | 0.02 | Antibiotic Anthracycline-like | 0.02 0.01 DBMET02102 | DBMET02102 | |
| 0.012 | 0.025 | 0.028 | Integrin beta7 antagonist | 0.028 0.01 DBMET02102 | DBMET02102 | |
| 0.056 | 0.069 | 0.068 | Potassium channel large-conductance Ca-activated activator | 0.068 0.047 DBMET02102 | DBMET02102 | |
| 0.035 | 0.048 | 0.057 | Geranyltranstransferase inhibitor | 0.057 0.016 DBMET02102 | DBMET02102 | |
| 0.031 | 0.045 | 0.036 | Retinoid X receptor antagonist | 0.036 0.029 DBMET02102 | DBMET02102 | |
| 0.098 | 0.113 | 0.111 | Transcription factor STAT6 inhibitor | 0.111 0.079 DBMET02102 | DBMET02102 | |
| 0.053 | 0.067 | 0.145 | Caspase 9 inhibitor | 0.145 0.006 DBMET02102 | DBMET02102 | |
| 0.028 | 0.043 | 0.195 | Glutamate (mGluR4) agonist | 0.195 0.003 DBMET02102 | DBMET02102 | |
| 0.01 | 0.026 | 0.016 | CXC chemokine 4 receptor agonist | 0.016 0.01 DBMET02102 | DBMET02102 | |
| 0.078 | 0.096 | 0.195 | Carbonic anhydrase III inhibitor | 0.195 0.017 DBMET02102 | DBMET02102 | |
| 0.005 | 0.022 | 0.015 | Carboxypeptidase B2 inhibitor | 0.015 0.005 DBMET02102 | DBMET02102 | |
| 0.033 | 0.051 | 0.06 | Glucagon-like peptide 1 receptor antagonist | 0.06 0.009 DBMET02102 | DBMET02102 | |
| 0.025 | 0.043 | 0.053 | Glutamate (mGluR group II) agonist | 0.053 0.014 DBMET02102 | DBMET02102 | |
| 0.02 | 0.039 | 0.105 | Caspase 2 inhibitor | 0.105 0.004 DBMET02102 | DBMET02102 | |
| 0.039 | 0.058 | 0.047 | Diacylglycerol O-acyltransferase inhibitor | 0.047 0.04 DBMET02102 | DBMET02102 | |
| 0.01 | 0.03 | 0.021 | Cholecystokinin agonist | 0.021 0.012 DBMET02102 | DBMET02102 | |
| 0.043 | 0.065 | 0.056 | Sphingosine kinase 2 inhibitor | 0.056 0.037 DBMET02102 | DBMET02102 | |
| 0.012 | 0.033 | 0.099 | Vitronectin receptor antagonist | 0.099 0.005 DBMET02102 | DBMET02102 | |
| 0.018 | 0.039 | 0.035 | Urotensin II agonist | 0.035 0.012 DBMET02102 | DBMET02102 | |
| 0.024 | 0.045 | 0.038 | Retinoid X alpha receptor agonist | 0.038 0.021 DBMET02102 | DBMET02102 | |
| 0.04 | 0.062 | 0.141 | Aminopeptidase microsomal inhibitor | 0.141 0.009 DBMET02102 | DBMET02102 | |
| 0.045 | 0.068 | 0.119 | Sphingosine 1-phosphate receptor 5 agonist | 0.119 0.006 DBMET02102 | DBMET02102 | |
| 0.01 | 0.034 | 0.025 | Thromboxane A2 agonist | 0.025 0.004 DBMET02102 | DBMET02102 | |
| 0.029 | 0.054 | 0.033 | Adenosine uptake inhibitor | 0.033 0.031 DBMET02102 | DBMET02102 | |
| 0.004 | 0.03 | 0.01 | Neurokinin 3 agonist | 0.01 0.009 DBMET02102 | DBMET02102 | |
| 0.052 | 0.078 | 0.067 | Elastase 1 inhibitor | 0.067 0.051 DBMET02102 | DBMET02102 | |
| 0.019 | 0.048 | 0.03 | Glutamate (mGluR2) agonist | 0.03 0.024 DBMET02102 | DBMET02102 | |
| 0.033 | 0.061 | 0.068 | GABA B receptor antagonist | 0.068 0.009 DBMET02102 | DBMET02102 | |
| 0.026 | 0.055 | 0.045 | Erythropoietin receptor agonist | 0.045 0.024 DBMET02102 | DBMET02102 | |
| 0.064 | 0.093 | 0.088 | Sphingosine 1-phosphate receptor antagonist | 0.088 0.032 DBMET02102 | DBMET02102 | |
| 0.162 | 0.191 | 0.233 | Transcription factor STAT3 inhibitor | 0.233 0.098 DBMET02102 | DBMET02102 | |
| 0.023 | 0.052 | 0.034 | Caspase 6 inhibitor | 0.034 0.014 DBMET02102 | DBMET02102 | |
| 0.01 | 0.039 | 0.018 | Purinergic P2Y1 agonist | 0.018 0.008 DBMET02102 | DBMET02102 | |
| 0.127 | 0.157 | 0.26 | Non-steroidal antiinflammatory agent | 0.26 0.039 DBMET02102 | DBMET02102 | |
| 0.069 | 0.1 | 0.136 | Protease inhibitor | 0.136 0.037 DBMET02102 | DBMET02102 | |
| 0.051 | 0.082 | 0.09 | Interferon inducer | 0.09 0.017 DBMET02102 | DBMET02102 | |
| 0.13 | 0.162 | 0.296 | Catenin beta inhibitor | 0.296 0.005 DBMET02102 | DBMET02102 | |
| 0.117 | 0.151 | 0.133 | CF transmembrane conductance regulator agonist | 0.133 0.111 DBMET02102 | DBMET02102 | |
| 0.027 | 0.062 | 0.122 | Aminopeptidase N inhibitor | 0.122 0.009 DBMET02102 | DBMET02102 | |
| 0.056 | 0.09 | 0.064 | Exportin-1 inhibitor | 0.064 0.058 DBMET02102 | DBMET02102 | |
| 0.06 | 0.095 | 0.102 | Carbonic anhydrase VI inhibitor | 0.102 0.038 DBMET02102 | DBMET02102 | |
| 0.117 | 0.153 | 0.226 | Pyruvate kinase inhibitor | 0.226 0.069 DBMET02102 | DBMET02102 | |
| 0.018 | 0.054 | 0.033 | Retinoid X receptor agonist | 0.033 0.027 DBMET02102 | DBMET02102 | |
| 0.008 | 0.044 | 0.046 | Integrin alpha4beta7 antagonist | 0.046 0.005 DBMET02102 | DBMET02102 | |
| 0.023 | 0.06 | 0.033 | Opioid delta receptor agonist | 0.033 0.029 DBMET02102 | DBMET02102 | |
| 0.014 | 0.051 | 0.032 | Prostaglandin F2 alpha agonist | 0.032 0.008 DBMET02102 | DBMET02102 | |
| 0.078 | 0.115 | 0.096 | AMP-activated protein kinase stimulant | 0.096 0.075 DBMET02102 | DBMET02102 | |
| 0.03 | 0.068 | 0.05 | Opioid agonist | 0.05 0.039 DBMET02102 | DBMET02102 | |
| 0.024 | 0.064 | 0.193 | Endothelin-converting enzyme inhibitor | 0.193 0.005 DBMET02102 | DBMET02102 | |
| 0.014 | 0.057 | 0.035 | Isoleucine-tRNA ligase inhibitor | 0.035 0.004 DBMET02102 | DBMET02102 | |
| 0.004 | 0.051 | 0.278 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.278 0.003 DBMET02102 | DBMET02102 | |
| 0.01 | 0.059 | 0.043 | Cholecystokinin B antagonist | 0.043 0.013 DBMET02102 | DBMET02102 | |
| 0.086 | 0.135 | 0.264 | Toll-Like receptor 2 antagonist | 0.264 0.007 DBMET02102 | DBMET02102 | |
| 0.096 | 0.145 | 0.151 | DNA repair enzyme inhibitor | 0.151 0.03 DBMET02102 | DBMET02102 | |
| 0.025 | 0.075 | 0.123 | Ribonucleotide reductase inhibitor | 0.123 0.016 DBMET02102 | DBMET02102 | |
| 0.025 | 0.076 | 0.124 | Ribonucleoside-diphosphate reductase inhibitor | 0.124 0.015 DBMET02102 | DBMET02102 | |
| 0.045 | 0.096 | 0.057 | Immunoglobulin Fc receptor antagonist | 0.057 0.033 DBMET02102 | DBMET02102 | |
| 0.025 | 0.078 | 0.034 | HCV polyprotein inhibitor | 0.034 0.023 DBMET02102 | DBMET02102 | |
| 0.034 | 0.089 | 0.045 | Dopamine beta hydroxylase inhibitor | 0.045 0.043 DBMET02102 | DBMET02102 | |
| 0.015 | 0.071 | 0.073 | Calcium-sensing receptor agonist | 0.073 0.004 DBMET02102 | DBMET02102 | |
| 0.018 | 0.075 | 0.026 | Complement factor 1s inhibitor | 0.026 0.016 DBMET02102 | DBMET02102 | |
| 0.097 | 0.154 | 0.13 | Mannose-6-phosphate isomerase inhibitor | 0.13 0.085 DBMET02102 | DBMET02102 | |
| 0.017 | 0.073 | 0.043 | Phosphoglycerate kinase inhibitor | 0.043 0.018 DBMET02102 | DBMET02102 | |
| 0.007 | 0.065 | 0.031 | Prostaglandin H2 antagonist | 0.031 0.012 DBMET02102 | DBMET02102 | |
| 0.054 | 0.111 | 0.067 | Peroxisome proliferator-activated receptor gamma antagonist | 0.067 0.063 DBMET02102 | DBMET02102 | |
| 0.013 | 0.071 | 0.07 | Cholecystokinin antagonist | 0.07 0.014 DBMET02102 | DBMET02102 | |
| 0.005 | 0.064 | 0.025 | Ileal bile acid transport inhibitor | 0.025 0.006 DBMET02102 | DBMET02102 | |
| 0.007 | 0.066 | 0.021 | Dipeptidyl peptidase IX inhibitor | 0.021 0.008 DBMET02102 | DBMET02102 | |
| 0.067 | 0.126 | 0.11 | Lanosterol 14 alpha demethylase inhibitor | 0.11 0.041 DBMET02102 | DBMET02102 | |
| 0.045 | 0.104 | 0.064 | Leukotriene C antagonist | 0.064 0.021 DBMET02102 | DBMET02102 | |
| 0.017 | 0.077 | 0.036 | ATP citrate lysase inhibitor | 0.036 0.016 DBMET02102 | DBMET02102 | |
| 0.029 | 0.089 | 0.079 | Plasminogen activator inhibitor antagonist | 0.079 0.015 DBMET02102 | DBMET02102 | |
| 0.011 | 0.074 | 0.027 | Factor VII inhibitor | 0.027 0.023 DBMET02102 | DBMET02102 | |
| 0.157 | 0.221 | 0.227 | Transcription factor STAT inhibitor | 0.227 0.104 DBMET02102 | DBMET02102 | |
| 0.007 | 0.071 | 0.015 | Cholecystokinin A agonist | 0.015 0.012 DBMET02102 | DBMET02102 | |
| 0.019 | 0.084 | 0.054 | Purinergic P2Y antagonist | 0.054 0.023 DBMET02102 | DBMET02102 | |
| 0.011 | 0.077 | 0.024 | Geranylgeranyltransferase inhibitor | 0.024 0.013 DBMET02102 | DBMET02102 | |
| 0.029 | 0.096 | 0.086 | Maillard reaction inhibitor | 0.086 0.022 DBMET02102 | DBMET02102 | |
| 0.003 | 0.071 | 0.028 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.028 0.002 DBMET02102 | DBMET02102 | |
| 0.007 | 0.075 | 0.018 | Dipeptidyl peptidase VIII inhibitor | 0.018 0.008 DBMET02102 | DBMET02102 | |
| 0.028 | 0.098 | 0.041 | Leukotriene C4 antagonist | 0.041 0.022 DBMET02102 | DBMET02102 | |
| 0.051 | 0.122 | 0.131 | Histamine N-methyltransferase inhibitor | 0.131 0.023 DBMET02102 | DBMET02102 | |
| 0.022 | 0.093 | 0.051 | Carbonic anhydrase VB inhibitor | 0.051 0.043 DBMET02102 | DBMET02102 | |
| 0.077 | 0.149 | 0.137 | TRPA1 agonist | 0.137 0.041 DBMET02102 | DBMET02102 | |
| 0.119 | 0.192 | 0.2 | Neurotrophic factor enhancer | 0.2 0.076 DBMET02102 | DBMET02102 | |
| 0.054 | 0.131 | 0.223 | Inducible nitric-oxide synthase inhibitor | 0.223 0.006 DBMET02102 | DBMET02102 | |
| 0.024 | 0.102 | 0.092 | Neuropeptide agonist | 0.092 0.029 DBMET02102 | DBMET02102 | |
| 0.012 | 0.091 | 0.033 | Bradykinin B2 receptor agonist | 0.033 0.016 DBMET02102 | DBMET02102 | |
| 0.013 | 0.093 | 0.043 | Methionyl aminopeptidase 1 inhibitor | 0.043 0.01 DBMET02102 | DBMET02102 | |
| 0.009 | 0.091 | 0.057 | Kynurenine 3 monooxygenase inhibitor | 0.057 0.005 DBMET02102 | DBMET02102 | |
| 0.023 | 0.111 | 0.049 | Neurokinin 2 agonist | 0.049 0.02 DBMET02102 | DBMET02102 | |
| 0.009 | 0.099 | 0.032 | Integrin alphaVbeta1 antagonist | 0.032 0.005 DBMET02102 | DBMET02102 | |
| 0.024 | 0.114 | 0.035 | Calcium-independent phospholipase A2 inhibitor | 0.035 0.021 DBMET02102 | DBMET02102 | |
| 0.008 | 0.099 | 0.069 | Cholecystokinin A antagonist | 0.069 0.015 DBMET02102 | DBMET02102 | |
| 0.035 | 0.129 | 0.074 | Carbonic anhydrase XIII inhibitor | 0.074 0.054 DBMET02102 | DBMET02102 | |
| 0.007 | 0.103 | 0.019 | Thyroid hormone alpha agonist | 0.019 0.008 DBMET02102 | DBMET02102 | |
| 0.026 | 0.122 | 0.16 | Glutamate (mGluR) agonist | 0.16 0.013 DBMET02102 | DBMET02102 | |
| 0.037 | 0.135 | 0.127 | Sirtuin 1 inhibitor | 0.127 0.012 DBMET02102 | DBMET02102 | |
| 0.125 | 0.225 | 0.447 | Hypoglycemic | 0.447 0.021 DBMET02102 | DBMET02102 | |
| 0.008 | 0.108 | 0.016 | Integrin beta6 antagonist | 0.016 0.006 DBMET02102 | DBMET02102 | |
| 0.071 | 0.173 | 0.216 | Lipid peroxidase inhibitor | 0.216 0.036 DBMET02102 | DBMET02102 | |
| 0.03 | 0.134 | 0.187 | Sphingosine 1-phosphate receptor 4 agonist | 0.187 0.005 DBMET02102 | DBMET02102 | |
| 0.026 | 0.131 | 0.217 | Selectin antagonist | 0.217 0.01 DBMET02102 | DBMET02102 | |
| 0.052 | 0.159 | 0.231 | Glutathione S-transferase inhibitor | 0.231 0.004 DBMET02102 | DBMET02102 | |
| 0.075 | 0.184 | 0.167 | Interleukin 8 antagonist | 0.167 0.025 DBMET02102 | DBMET02102 | |
| 0.035 | 0.146 | 0.053 | DNA helicase inhibitor | 0.053 0.04 DBMET02102 | DBMET02102 | |
| 0.058 | 0.17 | 0.163 | DNA polymerase I inhibitor | 0.163 0.042 DBMET02102 | DBMET02102 | |
| 0.016 | 0.128 | 0.106 | Macrophage elastase inhibitor | 0.106 0.009 DBMET02102 | DBMET02102 | |
| 0.005 | 0.118 | 0.021 | Purinergic P2T antagonist | 0.021 0.015 DBMET02102 | DBMET02102 | |
| 0.03 | 0.143 | 0.062 | Carbonic anhydrase VA inhibitor | 0.062 0.057 DBMET02102 | DBMET02102 | |
| 0.014 | 0.128 | 0.045 | Carbonic anhydrase I stimulant | 0.045 0.02 DBMET02102 | DBMET02102 | |
| 0.031 | 0.144 | 0.059 | Epithelial sodium channel blocker | 0.059 0.03 DBMET02102 | DBMET02102 | |
| 0.008 | 0.123 | 0.064 | Endothelial nitric-oxide synthase inhibitor | 0.064 0.007 DBMET02102 | DBMET02102 | |
| 0.016 | 0.131 | 0.038 | Factor XIIIa inhibitor | 0.038 0.025 DBMET02102 | DBMET02102 | |
| 0.025 | 0.141 | 0.066 | Human rhinovirus A protease inhibitor | 0.066 0.031 DBMET02102 | DBMET02102 | |
| 0.017 | 0.136 | 0.059 | Thromboxane A2 antagonist | 0.059 0.029 DBMET02102 | DBMET02102 | |
| 0.102 | 0.224 | 0.306 | Free radical scavenger | 0.306 0.05 DBMET02102 | DBMET02102 | |
| 0.033 | 0.157 | 0.106 | Prostaglandin F2 alpha antagonist | 0.106 0.009 DBMET02102 | DBMET02102 | |
| 0.019 | 0.146 | 0.059 | Thromboxane antagonist | 0.059 0.033 DBMET02102 | DBMET02102 | |
| 0.024 | 0.153 | 0.053 | VCAM-1 antagonist | 0.053 0.008 DBMET02102 | DBMET02102 | |
| 0.024 | 0.153 | 0.053 | VCAM antagonist | 0.053 0.008 DBMET02102 | DBMET02102 | |
| 0.018 | 0.147 | 0.054 | Collagenase inhibitor | 0.054 0.024 DBMET02102 | DBMET02102 | |
| 0.044 | 0.18 | 0.169 | Mediator release inhibitor | 0.169 0.021 DBMET02102 | DBMET02102 | |
| 0.028 | 0.166 | 0.068 | Botulinum neurotoxin type A inhibitor | 0.068 0.027 DBMET02102 | DBMET02102 | |
| 0.013 | 0.151 | 0.039 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.039 0.018 DBMET02102 | DBMET02102 | |
| 0.104 | 0.244 | 0.36 | Antioxidant | 0.36 0.044 DBMET02102 | DBMET02102 | |
| 0.109 | 0.253 | 0.336 | DNA damaging | 0.336 0.045 DBMET02102 | DBMET02102 | |
| 0.024 | 0.168 | 0.056 | Leukotriene B4 antagonist | 0.056 0.032 DBMET02102 | DBMET02102 | |
| 0.028 | 0.174 | 0.065 | Carbonic anhydrase II stimulant | 0.065 0.018 DBMET02102 | DBMET02102 | |
| 0.013 | 0.161 | 0.027 | Thrombin receptor antagonist | 0.027 0.022 DBMET02102 | DBMET02102 | |
| 0.039 | 0.187 | 0.06 | Lipocortins synthesis agonist | 0.06 0.035 DBMET02102 | DBMET02102 | |
| 0.057 | 0.21 | 0.114 | Alkaline phosphatase inhibitor | 0.114 0.093 DBMET02102 | DBMET02102 | |
| 0.08 | 0.238 | 0.548 | Growth hormone agonist | 0.548 0.004 DBMET02102 | DBMET02102 | |
| 0.035 | 0.199 | 0.107 | Myeloperoxidase inhibitor | 0.107 0.028 DBMET02102 | DBMET02102 | |
| 0.038 | 0.204 | 0.102 | Urease inhibitor | 0.102 0.064 DBMET02102 | DBMET02102 | |
| 0.007 | 0.179 | 0.125 | Kinesin-like protein 1 inhibitor | 0.125 0.005 DBMET02102 | DBMET02102 | |
| 0.007 | 0.179 | 0.125 | Kinesin antagonist | 0.125 0.005 DBMET02102 | DBMET02102 | |
| 0.004 | 0.181 | 0.018 | Free fatty acid receptor 1 agonist | 0.018 0.012 DBMET02102 | DBMET02102 | |
| 0.053 | 0.241 | 0.115 | Toll-Like receptor 4 antagonist | 0.115 0.048 DBMET02102 | DBMET02102 | |
| 0.005 | 0.195 | 0.032 | Sphingosine 1-phosphate receptor 3 agonist | 0.032 0.026 DBMET02102 | DBMET02102 | |
| 0.049 | 0.24 | 0.13 | Transcription factor NF kappa B stimulant | 0.13 0.021 DBMET02102 | DBMET02102 | |
| 0.019 | 0.219 | 0.066 | Leukotriene antagonist | 0.066 0.044 DBMET02102 | DBMET02102 | |
| 0.004 | 0.21 | 0.02 | Prostacyclin agonist | 0.02 0.008 DBMET02102 | DBMET02102 | |
| 0.054 | 0.261 | 0.131 | Antibacterial (Helicobacter pylori) | 0.131 0.067 DBMET02102 | DBMET02102 | |
| 0.011 | 0.221 | 0.31 | Glycine transporter 2 inhibitor | 0.31 0.004 DBMET02102 | DBMET02102 | |
| 0.006 | 0.218 | 0.114 | Complement C3a chemotactic receptor antagonist | 0.114 0.006 DBMET02102 | DBMET02102 | |
| 0.014 | 0.232 | 0.073 | Dihydrofolate reductase inhibitor | 0.073 0.005 DBMET02102 | DBMET02102 | |
| 0.015 | 0.238 | 0.061 | Peroxisome proliferator-activated receptor gamma agonist | 0.061 0.057 DBMET02102 | DBMET02102 | |
| 0.069 | 0.3 | 0.167 | Interleukin 6 antagonist | 0.167 0.068 DBMET02102 | DBMET02102 | |
| 0.034 | 0.296 | 0.326 | Aminoacyl-tRNA synthetase inhibitor | 0.326 0.005 DBMET02102 | DBMET02102 | |
| 0.018 | 0.281 | 0.097 | Nitric oxide donor | 0.097 0.01 DBMET02102 | DBMET02102 | |
| 0.003 | 0.266 | 0.014 | Calcium-dependent phospholipase A2 inhibitor | 0.014 0.007 DBMET02102 | DBMET02102 | |
| 0.053 | 0.339 | 0.171 | Hypolipemic | 0.171 0.118 DBMET02102 | DBMET02102 | |
| 0.005 | 0.298 | 0.037 | HMG CoA reductase inhibitor | 0.037 0.019 DBMET02102 | DBMET02102 | |
| 0.004 | 0.323 | 0.026 | Leukotriene B4 receptor 1 antagonist | 0.026 0.021 DBMET02102 | DBMET02102 | |
| 0.005 | 0.326 | 0.091 | Prostacyclin antagonist | 0.091 0.005 DBMET02102 | DBMET02102 | |
| 0.005 | 0.326 | 0.048 | Purinergic P2Y12 antagonist | 0.048 0.007 DBMET02102 | DBMET02102 | |
| 0.034 | 0.37 | 0.105 | Beta amyloid protein antagonist | 0.105 0.083 DBMET02102 | DBMET02102 | |
| 0.009 | 0.368 | 0.019 | Granulocyte colony stimulating factor receptor agonist | 0.019 0.012 DBMET02102 | DBMET02102 | |
| 0.078 | 0.458 | 0.201 | Toll-Like receptor 7 agonist | 0.201 0.199 DBMET02102 | DBMET02102 | |
| 0.075 | 0.462 | 0.236 | Toll-Like receptor agonist | 0.236 0.162 DBMET02102 | DBMET02102 | |
| 0.012 | 0.402 | 0.075 | Farnesyltransferase inhibitor | 0.075 0.014 DBMET02102 | DBMET02102 | |
| 0.038 | 0.443 | 0.256 | Platelet aggregation inhibitor | 0.256 0.049 DBMET02102 | DBMET02102 | |
| 0.031 | 0.462 | 0.099 | Vanilloid agonist | 0.099 0.034 DBMET02102 | DBMET02102 | |
| 0.017 | 0.576 | 0.042 | Parathyroid hormone antagonist | 0.042 0.041 DBMET02102 | DBMET02102 | |
| 0.018 | 0.612 | 0.195 | Thioredoxin inhibitor | 0.195 0.009 DBMET02102 | DBMET02102 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |